MyFinsight
Home
Blog
About
Marketable debt
securities,...
$149,825K
(-39.84%↓ Y/Y)
Cash and cash
equivalents
$24,783K
(-34.09%↓ Y/Y)
Prepaid expenses and
other current assets
$6,671K
(-18.30%↓ Y/Y)
Total current assets
$181,279K
(-41.82%↓ Y/Y)
Operating
leaseright-of-useassets
$24,795K
(-20.47%↓ Y/Y)
Prepaid expenses and
other assets
$4,129K
(28.15%↑ Y/Y)
Restricted cash
$2,627K
(0.00%↑ Y/Y)
Property and equipment,
net
$2,500K
(-19.02%↓ Y/Y)
Total assets
$215,330K
(-38.78%↓ Y/Y)
Total liabilities and
stockholders equity
$215,330K
(-38.78%↓ Y/Y)
Total stockholders
equity
$143,646K
(-47.67%↓ Y/Y)
Total liabilities
$71,684K
(-7.16%↓ Y/Y)
Accumulated deficit
-$1,269,093K
(-12.35%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$78K
(-232.20%↓ Y/Y)
Additional paid-in capital
$1,412,745K
(0.63%↑ Y/Y)
Total current
liabilities
$37,626K
(-3.58%↓ Y/Y)
Long-term lease liability
$33,558K
(-10.96%↓ Y/Y)
Other long-term
liabilities
$500K
(0.00%↑ Y/Y)
Common stock, 0.001 par
value 250,000,000...
$72K
(0.00%↑ Y/Y)
Accrued expenses
$29,484K
(-16.48%↓ Y/Y)
Accounts payable
$8,142K
(118.93%↑ Y/Y)
Back
Back
Balance Sheet
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL)
source: myfinsight.com